123 related articles for article (PubMed ID: 9492260)
1. Preventing and treating azole-resistant oropharyngeal candidiasis in HIV-infected patients.
Penzak SR; Gubbins PO
Am J Health Syst Pharm; 1998 Feb; 55(3):279-83. PubMed ID: 9492260
[No Abstract] [Full Text] [Related]
2. Candidiasis at ICAAC.
Barr D; Smart T
GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole prevents yeast infections in women with HIV.
AIDS Patient Care STDS; 1996 Oct; 10(5):310. PubMed ID: 11361529
[No Abstract] [Full Text] [Related]
4. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.
Schuman P; Capps L; Peng G; Vazquez J; el-Sadr W; Goldman AI; Alston B; Besch CL; Vaughn A; Thompson MA; Cobb MN; Kerkering T; Sobel JD
Ann Intern Med; 1997 May; 126(9):689-96. PubMed ID: 9139554
[TBL] [Abstract][Full Text] [Related]
5. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Patton LL; Bonito AJ; Shugars DA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):170-9. PubMed ID: 11505264
[TBL] [Abstract][Full Text] [Related]
7. The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
Blignaut E; Botes ME; Nieman HL
SADJ; 1999 Dec; 54(12):605-8. PubMed ID: 16892568
[TBL] [Abstract][Full Text] [Related]
8. Triazole therapy for mucocutaneous candidiasis in HIV-infected patients.
Thomas CJ
J Assoc Nurses AIDS Care; 1998; 9(5):36-44. PubMed ID: 9742479
[TBL] [Abstract][Full Text] [Related]
9. Reduction in oropharyngeal candidiasis following introduction of protease inhibitors.
Hood S; Bonington A; Evans J; Denning D
AIDS; 1998 Mar; 12(4):447-8. PubMed ID: 9520182
[No Abstract] [Full Text] [Related]
10. Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy.
Valdez H; Gripshover BM; Salata RA; Lederman MM
AIDS; 1998 Mar; 12(5):538. PubMed ID: 9543458
[No Abstract] [Full Text] [Related]
11. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.
Gripshover BM; Valdez H; Salata RA; Lederman MM
AIDS; 1998 Dec; 12(18):2513-4. PubMed ID: 9875599
[No Abstract] [Full Text] [Related]
12. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
[TBL] [Abstract][Full Text] [Related]
13. Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
Walmsley S; King S; McGeer A; Ye Y; Richardson S
Clin Infect Dis; 2001 Jun; 32(11):1554-61. PubMed ID: 11340526
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.
De Wit S; O'Doherty E; De Vroey C; Clumeck N
J Int Med Res; 1998; 26(3):159-70. PubMed ID: 9718471
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of candidiasis and cryptococcosis in AIDS].
Just-Nübling G
Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
[TBL] [Abstract][Full Text] [Related]
16. [Fluconazole (Diflucan): its clinical spectrum and development].
Espejo Martínez J; Alvarez Medina MP; Sánchez Morales S
Rev Clin Esp; 1997 Apr; 197 Suppl 1():86-93. PubMed ID: 9297211
[No Abstract] [Full Text] [Related]
17. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.
Phillips P; De Beule K; Frechette G; Tchamouroff S; Vandercam B; Weitner L; Hoepelman A; Stingl G; Clotet B
Clin Infect Dis; 1998 Jun; 26(6):1368-73. PubMed ID: 9636865
[TBL] [Abstract][Full Text] [Related]
18. Azole drug resistance in yeasts.
Johnson EM; Warnock DW
J Antimicrob Chemother; 1995 Nov; 36(5):751-5. PubMed ID: 8626255
[No Abstract] [Full Text] [Related]
19. Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870.
Hood SV; Hollis S; Percy M; Atkinson G; Williams K; Denning DW
Clin Infect Dis; 1999 Mar; 28(3):587-96. PubMed ID: 10194083
[TBL] [Abstract][Full Text] [Related]
20. Oropharyngeal and esophageal candidiasis in HIV disease: emerging pathogens, changing therapies.
AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S1-25; quiz S26-7. PubMed ID: 11361744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
